These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 27979812)
1. Opioid manufacturer bribed doctors to prescribe fentanyl inappropriately, US says. Dyer O BMJ; 2016 Dec; 355():i6742. PubMed ID: 27979812 [No Abstract] [Full Text] [Related]
2. Association of Pharmaceutical Manufacturer Payments to Physicians and Prescribing Dosage of Opioids. Fleischman W; Agrawal S; Gross CP; Ross JS J Gen Intern Med; 2019 Jul; 34(7):1074-1076. PubMed ID: 31011967 [No Abstract] [Full Text] [Related]
3. The role of fentanyl in the treatment of breakthrough cancer pain: Different biotechnologies, different results and different drug costs. Giuliani J; Fiorica F; Sacchetto A; Franceschini G; Vaccari F; Bonetti A J Oncol Pharm Pract; 2021 Mar; 27(2):445-447. PubMed ID: 33356990 [TBL] [Abstract][Full Text] [Related]
4. Are there cost benefits to fentanyl for breakthrough pain? Davis MP J Pain Symptom Manage; 2012 Sep; 44(3):e1-2. PubMed ID: 22939453 [No Abstract] [Full Text] [Related]
5. Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment. Cortesi PA; D'Angiolella LS; Vellucci R; Allegri M; Casale G; Favaretti C; Kheiraoui F; Cesana G; Mantovani LG PLoS One; 2017; 12(6):e0179523. PubMed ID: 28654672 [TBL] [Abstract][Full Text] [Related]
6. Barriers to the use of buccal and intranasal fentanyl for breakthrough pain in paediatric palliative care: an exploratory survey. Harrop E; Jamieson L; Choy TH; Ho WHP; Wong ICK BMJ Support Palliat Care; 2018 Sep; 8(3):355-356. PubMed ID: 28801316 [No Abstract] [Full Text] [Related]
7. [Transmucosal fentanyl and breakthrough pain: The other side of the coin]. Henche Ruiz AI Rev Esp Geriatr Gerontol; 2020; 55(1):56-57. PubMed ID: 31307779 [No Abstract] [Full Text] [Related]
8. Use of oral formulations of fentanyl for breakthrough cancer pain. Handsaker S; Dempsey L; Fabby C Int J Palliat Nurs; 2015 Apr; 21(4):168, 170-2. PubMed ID: 25901588 [No Abstract] [Full Text] [Related]
9. Concentration of Opioid-Related Industry Payments in Opioid Crisis Areas. Lee AJ; Bandari J; Macleod LC; Davies BJ; Jacobs BL J Gen Intern Med; 2019 Feb; 34(2):187-189. PubMed ID: 30402818 [No Abstract] [Full Text] [Related]
10. [Not all pains are the same: breakthrough pain in cancer patients. A case report]. Gunnellini M Recenti Prog Med; 2018 Nov; 109(11):6e-10e. PubMed ID: 30565580 [TBL] [Abstract][Full Text] [Related]
11. Fentanyl sublingual spray for breakthrough cancer pain in patients receiving transdermal fentanyl. Alberts DS; Smith CC; Parikh N; Rauck RL Pain Manag; 2016 Oct; 6(5):427-34. PubMed ID: 27020837 [TBL] [Abstract][Full Text] [Related]
12. Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing. Hadland SE; Cerdá M; Li Y; Krieger MS; Marshall BDL JAMA Intern Med; 2018 Jun; 178(6):861-863. PubMed ID: 29799955 [TBL] [Abstract][Full Text] [Related]
13. Industry Payments to Physicians for Opioid Products, 2013-2015. Hadland SE; Krieger MS; Marshall BDL Am J Public Health; 2017 Sep; 107(9):1493-1495. PubMed ID: 28787210 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of transnasal fentanyl citrate for the treatment of breakthrough cancer pain. Ruggeri M; Turriziani A; Oradei M Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):459-64. PubMed ID: 24702061 [TBL] [Abstract][Full Text] [Related]
15. [Breaktrough cancer pain in metastatic prostate adenocarcinoma: a case report.]. Santeufemia DA; Miolo G Recenti Prog Med; 2019 Mar; 110(3):3e-5e. PubMed ID: 30968857 [TBL] [Abstract][Full Text] [Related]
16. Fentanyl pectin nasal spray for breakthrough cancer pain. Torres LM; Trinidad JM; Calderón E; Benitez D; Perelman M Int J Palliat Nurs; 2015 Mar; 21(3):114-6. PubMed ID: 25815759 [No Abstract] [Full Text] [Related]
17. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer. Gombert-Handoko KB Clin Ther; 2014 Nov; 36(11):1704. PubMed ID: 25048312 [No Abstract] [Full Text] [Related]
18. Breakthrough cancer pain: review and calls to action to improve its management. Camps Herrero C; Batista N; Díaz Fernández N; Escobar Álvarez Y; Gonzalo Gómez A; Isla Casado D; Salud A; Terrasa Pons J; Guillem Porta V Clin Transl Oncol; 2020 Aug; 22(8):1216-1226. PubMed ID: 32002739 [TBL] [Abstract][Full Text] [Related]
19. Fentanyl buccal film. New oral transmucosal form has no advantages in breakthrough pain. Prescrire Int; 2013 Oct; 22(142):237. PubMed ID: 24298583 [No Abstract] [Full Text] [Related]
20. [A New Therapeutic Approach for Cancer-Related Breakthrough Pain - Focused on Oral Transmucosal Fentanyl]. Yomiya K; Kaneshima M; Kyosaka B; Warita E; Hosonuma R; Osato S Gan To Kagaku Ryoho; 2017 Apr; 44(4):289-293. PubMed ID: 28428506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]